American International Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-19,671
Closed -$149K 3309
2022
Q1
$149K Sell
19,671
-1,385
-7% -$13.1K ﹤0.01% 2419
2021
Q4
$215K Sell
21,056
-402
-2% -$5.12K ﹤0.01% 2325
2021
Q3
$288K Sell
21,458
-510
-2% -$8.31K ﹤0.01% 2208
2021
Q2
$482 Buy
21,968
+2,087
+10% +$46.4K ﹤0.01% 1951
2021
Q1
$478 Buy
19,881
+52
+0.3% +$1.21K ﹤0.01% 1868
2020
Q4
$357 Sell
19,829
-569
-3% -$8.5K ﹤0.01% 1942
2020
Q3
$236K Sell
20,398
-464
-2% -$7.66K ﹤0.01% 2040
2020
Q2
$506K Buy
20,862
+833
+4% +$13.8K ﹤0.01% 1581
2020
Q1
$221K Sell
20,029
-1,157
-5% -$21.6K ﹤0.01% 1856
2019
Q4
$560K Sell
21,186
-179
-0.8% -$4.19K ﹤0.01% 1634
2019
Q3
$487K Sell
21,365
-150
-0.7% -$4.73K ﹤0.01% 1673
2019
Q2
$660K Buy
21,515
+6,721
+45% +$141K ﹤0.01% 1545
2019
Q1
$246K Sell
14,794
-210
-1% -$3.98K ﹤0.01% 2106
2018
Q4
$287K Buy
15,004
+1,177
+9% +$44.1K ﹤0.01% 1968
2018
Q3
$723K Buy
13,827
+535
+4% +$29.2K ﹤0.01% 1660
2018
Q2
$578K Buy
13,292
+4,655
+54% +$199K ﹤0.01% 1735
2018
Q1
$320K Buy
8,637
+3,341
+63% +$89.2K ﹤0.01% 1977
2017
Q4
$105K Buy
5,296
+82
+2% +$1.76K ﹤0.01% 2704
2017
Q3
$130K Buy
+5,214
New +$96.3K ﹤0.01% 2516

Other funds holding GTHX

American International Group's GTHX Position: Q2 2022 in Review

American International Group sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2022, closing a stake of 19,671 shares — an estimated $149K sold.

American International Group first reported a position in GTHX in Q3 2017 and held it in 19 quarters. The position peaked at $723K in Q3 2018. 98 funds tracked by Wall St. Rank hold GTHX as of Q2 2022.

  • American International Group reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 19,671 G1 Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $149K.
  • American International Group first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2017 and held it in 19 quarters.
  • American International Group's G1 Therapeutics, Inc. Common Stock position peaked at $723K in Q3 2018.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.